Furthermore, c-Myc-induced upregulation of USP22 deubiquitinase promotes SIRT1 stability and subsequently confers protection against FLT3 inhibitors in FLT3-ITD AML LSCs [136]. Here, MYC is linked to acute myeloid leukemia.